Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kaufmann Ernest, Aeppli Stefanie, Affentranger Andres, Arnold Nicolas, Arnold Winfried, Aschwanden Fabian, Balermpas Panagiotis, Beyer Jörg, Bieri Uwe, Boormanns Joost, Cathomas Richard, Bari Berardino De, Dressler Marco, Engeler Daniel S, Erdmann Andreas, Gallina Andrea, Gomez Silvia, Guckenberger Matthias, Herrmann Thomas, Hermanns Thomas, Lucca Ilaria, John Hubert, Kessler Thomas Matthias, Klein Jan, Laouiti Mohamed, Lauffer David, Lerner Seth Paul, Mattei Agostino, Müntener Michael, Nguyen Daniel, Niederberger Philipp, Papachristofilou Alexandros, Prause Lukas, Putora Paul Martin, Reinhardt Karsten, Salati Emanuela, Sèbe Philippe, Shelan Mohamed, Sigg Silvan, Strebel Räto Thomas, Templeton Arnoud Jan, Vogl Ursula, Wettstein Marian Severin, Wyler Stephen, Zihler Deborah, Zilli Thomas, Zwahlen Daniel, Roth Beat, Fankhauser Christian Daniel
Аннотация
OBJECTIVE: A Swiss consensus meeting aimed to identify gaps in follow-up strategies and subsequently tailoring follow-up protocols after curative treatment for bladder cancer.
METHODS: A consensus meeting including participants from urology, oncology, radiation oncology, neuro-urology, international advisors, and patient representatives was held. 19 pre-formulated questions addressing follow-up duration, frequency, and modalities after radical cystectomy or trimodal therapy for bladder cancer were discussed and voted by participants.
RESULTS: 42 experts from 22 institutions participated in the meeting. Agreement was reached on several important elements of oncological and functional follow-up like risk-adapted follow-up and regular usage of patient reported outcome measures (PROMs) and 3 novel personalized follow-up schedules were suggested, balancing oncological surveillance, and monitoring functional complications.
CONCLUSION: We agreed on 3 newly developed Swiss follow up schedules for patients with bladder cancer who underwent cystectomy or trimodal therapy with curative intent; these protocols include stage-specific recommendations for type and timing of investigations to detect relapse combined with balanced measures to monitor functional complications such as PROMS and specific clinical examinations. These protocols will be evaluated in a prospective national multicentric cohort study.